{
    "course title": "28850 Pharmaceutical Process Development",
    "Danish title": "Pharmaceutical Process Development",
    "Language of instruction": "English",
    "Point( ECTS )": "5",
    "Course type": "MSc\nOffered as a single course\nGeneral competence course (MSc), Pharmaceutical Design and Engineering\nProgramme specific course (MSc), Pharmaceutical Design and Engineering",
    "Schedule": "Spring F5A (Wed 8-12)",
    "Location": "Campus Lyngby",
    "Scope and form": "Lectures, exercises and group work",
    "Duration of Course": "13 weeks",
    "Date of examination": "F5A, F5A",
    "Type of assessment": "Written examination and reports\n1 report",
    "Exam duration": "Written exam: 2 hours",
    "Aid": "All Aid - no access to the internet",
    "Evaluation": "7 step scale , internal examiner",
    "Responsible": "John Woodley , Lyngby Campus, Building 227 , jw@kt.dtu.dk",
    "Department": "28 Department of Chemical Engineering",
    "Registration Sign up": "At the Studyplanner",
    "Green challenge participation": "This course gives the student an opportunity to prepare a project that may participate in DTU's Study Conference on sustainability, climate technology, and the environment (GRÃ˜N DYST). More information http://www.groendyst.dtu.dk/english",
    "General course objectives": "General course objectives\n1. Explain the basis for current and most importantly, future pharmaceutical production processes (small and large molecules, generics and biosimilars) and their development.\n2. Describe the principles of the QbD/PAT philosophy as defined by FDA, as well as LEAN and GMP.",
    "Learning objectives": "A student who has met the objectives of the course will be able to:\nDescribe the production process for typical small-molecule pharmaceuticals.\nDescribe the production process for typical biopharmaceuticals.\nExplain the principles of QbD and PAT\nDescribe the development process and 'life-cycle' of a new pharmaceutical.\nDescribe the latest developments in the field of pharmaceutical development and production processes.\nExplain the principles of LEAN manufacturing.\nDescribe the different classes of pharmaceutical, biopharmaceutical, biosimilars and generics.\nExplain the principles of GMP manufacturing",
    "Content": "Introduction - future pharmaceuticals with increased complexity; trend towards therapeutic proteins; trend towards continuous processes based on FDA requirements; Small molecule production - future pharmaceutical production, including semi-synthetic approaches (fermentation and biocatalysis) and continuous processes as well as technologies for improved sustainability; Biopharmaceutical production - future biopharmaceutical production, including fermentation, cell culture, antibody processing and downstream processing and single use technology, alternative hosts; Protein and peptide modification; Antibody-drug conjugates; Process Development - pharmaceutical process development paradigms, including F3; PAT and QbD: Process Analytical Technology (PAT) and Quality-by-Design (QbD), GMP, LEAN.",
    "Course literature": "Material provided by teacher",
    "Last updated": "02. maj, 2024"
}